, respectively. In the same analysis corresponding specificities were 54% (13 negative scans of 24 benign lesions), 80% (103 of 129), and 84% (109 of 130).
Abstract
Background -Thoracic computed tomography (CT) provides most of the staging information needed before operation for lung cancer and can reduce the number of exploratory thoracotomies. In recent years a new immunoscintigraphic technique with anti-carcinoembryonic antigen (CEA) monoclonal antibodies has been shown to be effective in lung cancer staging. This study compares the yields of CT scans and immunoscintigraphy in the preoperative evaluation of the mediastinal lymph nodes of patients with non-small cell lung cancer. Methods -One hundred and thirty one patients believed on clinical grounds to have an operable non-small cell lung cancer were photoscanned with the indium-111 labelled F(ab')2 fragments of the antibody FO23C5. Both planar and single photoemission computed tomography (SPECT) thoracic views were recorded. CT scans of the thorax, abdomen, and brain were obtained in all patients. Seventy of the patients eventually underwent surgery, an additional seven underwent mediastinoscopy or mediastinotomy, and a further 10 had both cervical exploration and thoracotomy. Pathological evaluation of the mediastinal nodes was available in all 87 patients, but in only 80 of them was the diagnosis of lung cancer eventually confirmed. Results -The diagnostic accuracy of planar immunoscintigraphy, SPECT immunoscintigraphy, and CT scanning for N2 disease was 76%, 74%, and 71%, respectively. The corresponding sensitivity and specificity rates were 45%, 77%, 64% and 88%, 72%, and 74%. These were not significantly different. Conclusions -This study shows that anti-CEA immunoscintigraphy has no advantage over conventional CT scanning in assessing mediastinal lymphoadenopathy in patients with lung cancer. CT Characteristics of the injected radiopharmaceutical (dose of antibody fragments, total radioactivity, and radiolabelling efficiency) are shown in table 1. Planar spot images (anterior and posterior views of the thorax and abdomen, anterior and lateral views of the head) were acquired by a large field of view gamma camera (GE 400 ACT, General Electric, Milwaukee, Wisconsin, USA) fitted with a medium energy parallel hole collimator using a dual energy window (173-274 keV). Views were stored in a 128 x 128 matrix. At least one scintigraphic series, acquired 120 hours after the radio compound injection, was obtained. At each scanning time a 1500 K anterior view of the thorax was recorded while the other images were recorded for a preset time. After planar imaging SPECT views of the thorax were obtained. The patient was positioned supine with arms above the head and the thorax was centred underneath the camera. Sixty four planar images were collected around 3600 with a 64 x 64 word mode matrix. The acquisition time for each plane was 20-25 seconds. The 64 planar projections were reconstructed to transverse slices with the use of a Butterworth filter (cutoff frequencies 0 3-0 4 cyles/cm, power factor 20) at a two pixel thickness for each transverse (12-8mm thick) slice. A value of 0-04cm-1 was used as attenuation coefficient. Transverse sections were reorientated into the sagittal and coronal planes.
The criteria for the interpretation of immunoscintigraphic images have already been described in detail.'0 12 Mediastinal lesions were assigned to a definite nodal station according to topographical criteria and the ATS node mapping scheme.22 All immunoscintigraphy scans were interpreted by a specialist in nuclear medicine (A.B.) without the benefits of clinical information.
THORACIC COMPUTED TOMOGRAPHY
All thoracic CT scans were performed with a GE 9800 scanner (General Electric, Milwaukee, Wisconsin, USA). Sections 10 mm thick were obtained at 1 cm intervals during suspended inspiration from the lung apices to the upper abdomen. In selected cases 5 mm thick sections were obtained at 5 mm intervals through the region of interest. lodinated intravenous contrast medium (150 ml bolus and 100 ml in slow infusion) was injected before all studies. Appropriate windows were used for viewing both lungs and soft tissues. Mediastinal indication to radical surgery. At the end of presurgical staging 27 patients were judged inoperable based on unequivocal CT findings, nine withdrew their consent to a probably noncurative thoracotomy, and eight were found to have small cell lung cancer after enrollment and were given chemotherapy. Of the remaining 87 patients 70 underwent a resection, seven underwent mediastinoscopy or mediastinotomy alone, and 10 had both cervical or (parasternal) exploration and a thoracotomy. Seven had benign lesions and, histologically, the most frequent tumour cell type was squamous (43 of the 80 assessable patients with cancer). Fifty seven of these 80 lung tumours were in the distal bronchi. Table 1 summarises the clinical, scintigraphic, and pathological characteristics of the three groups of patients (131 registered, 87 assessable, and 80 with cancer). Table 2 shows the main findings of the study. True positive, true negative, false positive, and false negative results, along with the corresponding values (and 95% confidence interval) for sensitivity, specificity, and accuracy, are listed. Data refer to the two groups of patients -that is, all the assessable and those assessable with cancer-and to the three types of investigation -that is, planar immunoscintigraphy, SPECT immunoscintigraphy, and CT scanning. In patients with cancer, tumour lymph node extension to the mediastinum was equally detectable by all three techniques. Diagnostic accuracy was 76%, 74%, and 71% for planar immunoscintigraphy, SPECT immunoscintigraphy, and CT scanning, respectively; sensitivity ranged from 77% with SPECT immunoscintigraphy to 45% with planar immunoscintigraphy and specificity from 88% with planar immunoscintigraphy to 72% with SPECT immunoscintigraphy. There were no statistically significant differences with the MacNemar test. Planar immunoscintigraphy and SPECT immunoscintigraphy was the best matched combination since the first technique was the most specific and the latter the most sensitive. CT images retained intermediate status. All staging techniques shared a high negative predictive capability, with SPECT immunoscintigraphy approximating 90%. Overall, similar figures were obtained when the seven patients without lung cancer were included in the computation (table 2) . However, most findings in this subgroup of seven patients were falsely positive, particularly with SPECT immunoscintigraphy. Discussion Surgery remains the only prospect of cure in patients with non-small cell lung cancer.27
DETECTION OF MEDIASTINAL LYMPH NODE INVOLVEMENT
Ideally, the preoperative assessment of the mediastinum should save patients from futile surgery. On the other hand, patients should be offered a surgical cure if appropriate. The final evaluation of the mediastinum often depends on surgical staging procedures such as media- Buccheri In a previous report of 63 patients with lung cancer,10 where we investigated the diagnostic yield of total body scintigraphy with 11'In labelled F(ab')2 fragments of the anti-CEA monoclonal antibody F023C5, the diagnosis of mediastinal lymph node metastases was correct in about 85% of patients using both the clinical and the pathological reference criteria. We then decided to perform a formal comparison between diagnostic yields of CT scanning and anti-CEA immunoscintigraphy. A preliminary report of this comparison was published two years ago.'2 In the present study we report more mature data that are not substantially different. Current accuracy rates for N2 disease in pathologically documented cases are, respectively, 76% for planar immunoscintigraphy, 74% for SPECT immunoscintigraphy, and 71 % for CT scanning. However, the gain in accuracy appears negligible, and the accuracy of the three techniques and the predictive values of a negative test (81%, 89%, and 84%, respectively, for planar immunoscintigraphy, SPECT immunoscintigraphy, and CT scanning) are not significantly different and all are within the lowest boundary of an acceptable "filter test". It must be remembered also that the search for nodal metastases was the most promising application of anti-CEA immunoscintigraphy in lung cancer staging'2 and that immunoscintigraphy is a time consuming and very expensive technique. For all these reasons, we now feel that there is no justification to prefer anti-CEA immunoscintigraphy to standard CT scanning of the thorax.
In conclusion, we believe that in lung cancer the ideal non-invasive preoperative test is not yet available and thoracic CT scanning remains the standard test for large and/or central tumours.
